Although inhibition of COL11A1-induced FAO sensitized ovarian cancer cells to cisplatin treatment in vitro [64], there have been no clinical trials that use FAO inhibitors for cancer treatment yet. Here, COL11A1 is linked to ovarian carcinoma.